{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:27:41Z","timestamp":1781893661388,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ijid.2023.03.017","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T22:03:40Z","timestamp":1678831420000},"page":"196-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Safety and efficacy of inactivated COVID-19 vaccines in women vaccinated during the first trimester of pregnancy"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1696-8847","authenticated-orcid":false,"given":"Yan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenli","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2023.03.017_bib0001","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2023.03.017_bib0002","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2023.03.017_bib0003","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S1473-3099(21)00319-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1\/2 clinical trial","volume":"21","author":"Han","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2023.03.017_bib0004","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ajog.2020.08.002","article-title":"Maternal outcome of pregnant women admitted to intensive care units for coronavirus disease 2019","volume":"223","author":"Kim","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijid.2023.03.017_bib0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/antib9030038","article-title":"Is the host viral response and the immunogenicity of vaccines altered in pregnancy?","volume":"9","author":"Saeed","year":"2020","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.ijid.2023.03.017_bib0006","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ijgo.13713","article-title":"COVID-19 vaccine acceptance in pregnant women","volume":"154","author":"Goncu Ayhan","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijid.2023.03.017_bib0007","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/jog.14748","article-title":"Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan","volume":"47","author":"Hayakawa","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ijid.2023.03.017_bib0008","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/AOG.0000000000004367","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in neonatal cord blood after vaccination in pregnancy","volume":"137","author":"Gill","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijid.2023.03.017_bib0009","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/vaccines9060675","article-title":"Evaluation of SARS-CoV-2 spike protein antibody titers in cord blood after COVID-19 vaccination during pregnancy in polish healthcare workers: preliminary results","volume":"9","author":"Zdanowski","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2023.03.017_bib0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajog.2021.03.035","article-title":"Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy","volume":"225","author":"Mithal","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijid.2023.03.017_bib0011","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1080\/21645515.2021.1947099","article-title":"Cord blood antibody following maternal SARS-CoV-2 inactive vaccine (CoronaVac) administration during the pregnancy","volume":"17","author":"Soysal","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2023.03.017_bib0012","first-page":"380","article-title":"Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: decline in antibodies 12 weeks after two doses","volume":"27","author":"Zee","year":"2021","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ijid.2023.03.017_bib0013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2431-3-6","article-title":"A nearly continuous measure of birth weight for gestational age using a United States national reference","volume":"3","author":"Oken","year":"2003","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ijid.2023.03.017_bib0014","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc10-0719","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijid.2023.03.017_bib0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ijid.2023.03.017_bib0016","doi-asserted-by":"crossref","first-page":"e0385","DOI":"10.1590\/0037-8682-0385-2021","article-title":"Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: a case report","volume":"54","author":"Menegali","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.ijid.2023.03.017_bib0017","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ijid.2023.03.017_bib0018","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF","volume":"18","author":"Kwak-Kim","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ijid.2023.03.017_bib0019","first-page":"312","article-title":"Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: preliminary results","volume":"27","author":"Zee","year":"2021","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ijid.2023.03.017_bib0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.2021.8565","article-title":"Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial","volume":"326","author":"Al Kaabi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2023.03.017_bib0021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2023.03.017_bib0022","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2023.03.017_bib0023","article-title":"Safety and efficacy of Sinopharm vaccine (BBIBP-CorV) in elderly population of Faisalabad district of Pakistan","author":"Nadeem","year":"2022","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ijid.2023.03.017_bib0024","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(22)00094-0","article-title":"Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study","volume":"399","author":"Costa Clemens","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2023.03.017_bib0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12916-022-02353-w","article-title":"CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study","volume":"20","author":"Paixao","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.ijid.2023.03.017_bib0026","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamapediatrics.2021.0038","article-title":"Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios","volume":"175","author":"Flannery","year":"2021","journal-title":"JAMA Pediatr"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:11:35Z","timestamp":1761120695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971223000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":26,"alternative-id":["S1201971223000942"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2023.03.017","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of inactivated COVID-19 vaccines in women vaccinated during the first trimester of pregnancy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2023.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University,. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}